Association of the<i> MDM2</i> SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis

<div>Forest plot of overall cancer risk associated with<i> MDM2</i> SNP285 polymorphism by dominant model. For each study, the estimated OR and its 95% CI are plotted with a box and a horizontal line. <svg height="8.76399pt" id="M9" style="vertical-align:-0.9893103pt" version="1.1" viewbox="-0.0498162 -7.77468 9.05108 8.76399" width="9.05108pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M659 255L343 571L27 255L343 -61L659 255ZM582 255L343 16L104 255L343 494L582 255Z" id="g117-130"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="686" vert-adv-y="686"></glyph.data></g></svg>, pooled OR and its 95% CIs.</div>

Disease Markers

fig2

Figure 2

Figure 2: Association of the<i> MDM2</i> SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis 

Disease Markers

Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis

Figure 2